US Patent Issued to Jiangsu University on Sept. 9 for "Primer set of mycobacterium tuberculosis based on specific HRCA isothermal amplification and an application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,486, issued on Sept. 9, was assigned to Jiangsu University (Zhenjiang, China).

"Primer set of mycobacterium tuberculosis based on specific HRCA isothermal amplification and an application thereof" was invented by Zhen Zhang (Zhenjiang, China), Hu Zhang (Tai'an, China), Kun Zeng (Zhenjiang, China) and Ming Li (Zhenjiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A primer set of Mycobacterium tuberculosis based on specific hyperbranched rolling circle amplification (HRCA) isothermal amplification includes: Lock and Key series primers for a recognition stage, and Loop and Link primers for an amplification stage. Using the primer set for an ...